概括
尽管有大量的SARS-CoV-2药物试验,但在法国只推尼马特里尔维尔+里托纳维尔. 由于变体耐药性,不再建议使用单克隆抗体,从而限制了有效的COVID-19治疗方法.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 病毒学 病毒学
背景情况:
- 在疫情初期,许多药物被调查用于SARS-CoV-2治疗.
- 最初的审查确定了100多种潜在的COVID-19药物.
研究的目的:
- 审查COVID-19治疗选择的演变.
- 评估目前针对SARS-CoV-2感染的推治疗方法的现状.
主要方法:
- 对药物试验和治疗指南的文献综述.
- 对抗SARS-CoV-2变种药物疗效的分析.
- 对法国当前治疗建议的评估.
主要成果:
- 尼尔马特里尔维尔+里托纳维尔是法国首要推的治疗方法.
- 只有当尼尔马特雷尔维尔+里托纳维尔是禁忌时,雷梅西维尔才是另一种选择.
- 单克隆抗体 (tixagevimab/cilgavimab, casirivimab/imdevimab, sotrovimab) 不再被推使用,因为它们对变体的疗效降低了.
- 罗阿克特姆拉 (托西利祖马布) 只适用于需要氧气的皮质治疗的特定成年患者.
结论:
- 自大流行开始以来,有效的COVID-19治疗方法的数量显著减少.
- 需要持续评估,以确认剩余治疗候选者的最终作用.
- 变体进化对抗病毒疗法的长期疗效构成重大挑战.
相关概念视频
Pulmonary Tuberculosis V
204
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
204
Pneumonia IV: Management
360
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
360
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
268
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
268
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
Acute Respiratory Failure-V
166
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
166


